孟立锋;刘前程;吴敏华;刘鑫;周少华;

• 1:广西中医药大学
• 2:广西中医药大学第一附属医院

摘要(Abstract)：

<正>腹膜透析（Peritoneal dialysis,PD）是终末期肾脏病（end stagerenal disease,ESRD）患者有效的肾脏替代疗法，在我国已得到广泛应用。据统计，我国PD人口已逾9万人，占全球PD患者总人数的33%^([1])。尽管近年来PD患者生存率及技术存活率显著提高([1])。尽管近年来PD患者生存率及技术存活率显著提高^([2])，但是，由于腹膜炎、腹膜纤维化（perito-neal fibrosis,PF）、透析液的不相容性等原因导致许多患者无法接受长期PD。

关键词(KeyWords)： 腹膜纤维化;动物模型;中医药

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金资助项目(81860838);; 广西自然基金(2020JJA140292);; 广西中医药大学校级一般课题(xjyb056)

作者(Authors): 孟立锋;刘前程;吴敏华;刘鑫;周少华;

参考文献(References)：

• [1]Li P K,Chow K M,Van de Luijtgaarden W M,et al.C-hanges in the worldwide epidemiology of peritoneal dialysis[J].Nat Rev Nephrol,2016,13(2):90-103． [2]Yu X,Yang X.Peritoneal Dialysis in China:Meeting the Challenge of Chronic Kidney Failure[J].Am J Kidney Dis,2015,65(1):147-151． [3]Han S H,Ahn S V,Yun J Y,et al.Effects of icodextrinon patient survival and technique success in patients undergoing peritoneal dialysis[J].Proc Eur Dial Transplant Assoc Eur Ren Aen Assoc,2012,27(5):2044-2050． [4]Herzog R,Bender T O,Vychytil A,et al.Dynamic O-linked N-acetylglucosamine modification of proteins affects stress responses and survival of mesothelialcells exposed to peritoneal dialysis fluids[J].J Am Soc Nephrol,2014,25(12):2778-2788． [5]张禹，李忻阳，罗佩婷，等．间充质干细胞治疗腹膜透析相关性腹膜纤维化的研究进展[J]．中国血液净化，2020,19(5):317-319． [6]金蔚，倪兆慧．保护腹膜功能新认识[J]．中国血液净化，2019,18(3):145-148． [7]Wang Y,Shi Y,Tao M,et al.Peritoneal fibrosis and epigenetic modulation[J].Peritoneal dialysis international:journal of the International Society for Peritoneal Dialysis,2020,41(2):168-178． [8]Masashi Mizuno,Yasuhiko Ito,Yasuhiro Suzuki,et al.Recent Analysis of Status and Outcomes of Peritoneal Dialysis in the Tokai Area of Japan:the Second Report of the Tokai Peritoneal Dialysis Registry[J].Clin Exp Nephrol,2016,20(6):960-971． [9]Philip Kam-tao Li,Cheuk Chun Szeto,Beth Piraino,et al.Ispd Peritonitis Recommendations:2016 Update on Prevention and Treatment[J].Perit Dial Int,2016,36(5):313-314． [10]Charmaine E Lok,Jyothi R Thumma,Keith P Mccullough,et al.Catheter-related Infection and Septicemia:Impact of Seasonality and Modifiable Practices From the Dopps[J].Semin Dial,2014,27(1):72-77． [11]赵洁，莫超，史伟，等．活血化瘀类中药治疗腹膜纤维化机制的研究进展[J]．中华中医药学刊，2020,38(4):80-83． [12]Biernacka A,Dobaczewski M,Frangogiannis N G.TGF-beta signaling in fibrosis[J].Growth factors (Chur,Switzerland),2011,29(5):196-202． [13]Huang H,Zheng F,Dong X,et al.Allicin inhibits tubular epithelial-myofibroblast transdifferentiation under high glucose conditions in vitro[J].Exp Ther Med,2017,13(1):254-262． [14]Akman S,Koyun M,Gelen T,et al.Comparison of intraperitoneal antithrombin III and heparin in experimental peritonitis[J].Pediatr Nephrol,2008,23:1327-1330． [15]Ersoy R,Celik A,Yilmazo,et al.The effects of irbesartan and spironolactone in prevention of peritoneal fibrosis in rats[J].Perit Dial Int,2007,27(4):424-431． [16]Nicolas Hautem N,Johann Morelle,Amadou Sow,et al.The NLRP3 Inflammasome Has a Critical Role in Peritoneal Dialysis-Related Peritonitis[J].J Am Soc Nephrol,2017,28(7):2038-2052． [17]项协隆，林沁．腹膜纤维化大鼠模型研究进展[J]．医学综述，2010,16(10):1445-1447． [18]Park S H,Kim Y L,Lindholm B.Experimental encapsulating peritoneal sclerosis models:pathogenesis and treatment[J].Perit Dial Int,2008,28:21-28． [19]Ni J,McLoughlin R M,Brodovitch A,et al.Nitric oxide synthase isoforms play distinct roles during acute peritonitis[J].Nephrol Dial Transplant,2010,25:86-96． [20]Zhang L,Hao J B,Ren L S,et al.The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis[J].Lab Invest,2014,94:839-850． [21]朱启金．褪黑素和吡菲尼酮对大鼠腹膜透析相关性腹膜纤维化的影响[D]．合肥：安徽医科大学，2015． [22]杜少鹏．基于“脾主大腹”探讨健脾益气方调控PI3K/Akt/mTOR信号通路防治PD大鼠腹膜纤维化的机制研究[D]．南京：广西中医药大学，2018． [23]Kim J S,Cho K S,Park S H,et al.Itraconazole Attenuates Peritoneal Fibrosis Through Its Effect on the Sonic Hedgehog Signaling Pathway in Mice[J].Am J Nephrol,2018:456-464． [24]Xiong C,Liu N,Shao X,et al.Delayed administration of suramin attenuates peritoneal fibrosis in rats[J].BMCNephrology,2019,20(1):571-520． [25]Yu-Pei Fan,Ching-Chih Hsia,Kuang-wen Tseng,et al.The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton’s Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis[J].Stem Cells Transl Med,2015,5(2):235-247． [26]Nishimura H,Ito Y,Mizuno M,et al.Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model[J].Am J Physiol Renal Physiol,2008,294:F1084-1093． [27]Mizuno M,Ito Y.Rat models of acute and/or chronic peritoneal injuries including peritoneal fibrosis and peritoneal dialysis complications[J].Methods Mol Biol,2016,1397:35-43． [28]Hewitson T D,Smith E R,Holt S G.Rat Models of Acute and/or Chronic Peritoneal Injuries Including Peritoneal Fibrosis and Peritoneal Dialysis Complications[J].Methods Mol Biol,2016,1397(Chapter 4):35-43． [29]Guo H,Leung J C K,Lam M F,et al.Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis[J].J Am Soc Nephrol,2007,18 (10):2689-2703． [30]Liu L,Shi C X,Ghayur A,et al.Prolonged peritoneal gene expression using a helper-dependent adenovirus[J].Perit Dial Int,2009,29(5):508-516． [31]Wang J,Liu S,Li H,et al.A review of rodent models of peritoneal dialysis and its complications[J].Int Urol Nephrol,2015,47(1):209-215． [32]Kitamura M,Nishino T,Obata Y,et al.New Insights into Therapeutic Strategies for the Treatment of Peritoneal Fibrosis:Learning from Histochemical Analyses of Animal Models[J].Acta Histochem Cytochem,2014,47(4):133-143． [33]Wang J,Liu S,Li H,et al.A review of rodent models of peritoneal dialysis and its complications[J].Int Urol Nephrol,2015,47(1):209-215． [34]高勇，赵春军．不同剂量贝那普利治疗慢性充血性心力衰竭的临床疗效[J]．中国慢性病预防与控制，2017,25(7):545-548． [35]孟立锋，史伟，王夏青，等．中医药防治腹膜透析相关性腹膜纤维化研究进展[J/CD]．中华肾病研究电子杂志，2018,7(3):131-134． [36]姜新龙，邱芳晖．针灸辅助治疗早中期慢性肾功能衰竭对患者肾功能及预后的影响[J]．上海针灸杂志，2018,37(12):1363-1367． [37]Yu J S,Ho C H,Wang H Y,et al.Acupuncture on Renal Function in Patients with Chronic Kidney Disease:A Single-Blinded,Randomized,Preliminary Controlled Study[J].J Altern Complement Med,2017,23(8):624-631． [38]聂峰，杨茜芸，邓凯文，等．针灸协同治疗慢性移植肾肾病：随机对照研究[J]．中国针灸，2015,35 (11):1110-1114． [39]孟立锋，杨端云，史伟，等．健脾益气方调控间隙连接蛋白43防治PD大鼠腹膜损伤的作用机制研究[J]．湖南中医杂志，2020,36(70):157-161． [40]郑登勇，朱淑瑜，吴强．鳖甲煎丸对腹膜透析相关腹膜纤维化的影响及机制探讨[J]．中国现代医生，2020,58(9):32-35;193． [41]陈刚毅，苏保林，孟立锋，等．化痰祛瘀法对腹膜纤维化大鼠腹膜致密层厚度及SMA、E-cadherin蛋白表达的影响[J]．湖南中医杂志，2011,27(5):126-127.

文章评论(Comment)：